Literature DB >> 18407156

Lipoprotein-thyroid hormone interactions.

S Benvenga1, J Robbins.   

Abstract

A small but significant portion of the thyroid hormones that circulate in human plasma is associated with lipoproteins. Although the major lipoprotein carrier is HDL, the role of these interactions on T(4) entry into cells was tested first with LDL and human fibroblasts because of the well-characterized LDL receptors and the availability of cells with genetically absent receptors. It was shown that LDL enhanced the uptake of T(4) by cultured fibroblasts in which the LDL receptors were expressed. The T(4) binding sites on apolipoproteins B-100 and E, as well as apoA-I, have been partially characterized, and they exhibit considerable homology. A number of possible physiologic consequences of thyroid hormonelipoprotein interactions have been put forward as topics for further investigation.

Entities:  

Year:  1993        PMID: 18407156     DOI: 10.1016/1043-2760(93)90116-v

Source DB:  PubMed          Journal:  Trends Endocrinol Metab        ISSN: 1043-2760            Impact factor:   12.015


  7 in total

1.  Thyroxine binding to members and non-members of the serine protease inhibitor family.

Authors:  S Benvenga; D Lapa; F Trimarchi
Journal:  J Endocrinol Invest       Date:  2002-01       Impact factor: 4.256

2.  Re-evaluation of the thyroxine binding to human plasma lipoproteins using three techniques.

Authors:  S Benvenga; D Lapa; F Trimarchi
Journal:  J Endocrinol Invest       Date:  2001-05       Impact factor: 4.256

3.  Altered fructosamine and lipid fractions in subclinical hypothyroidism.

Authors:  Sridevi V Udupa; Poornima A Manjrekar; Vinit A Udupa; D'Souza Vivian
Journal:  J Clin Diagn Res       Date:  2013-01-01

Review 4.  A Review of the Pharmacokinetics of Levothyroxine for the Treatment of Hypothyroidism.

Authors:  Philippe Colucci; Corinne Seng Yue; Murray Ducharme; Salvatore Benvenga
Journal:  Eur Endocrinol       Date:  2013-03-15

Review 5.  Subclinical thyroid disorders: the menace of the Trojan horse.

Authors:  L H Duntas
Journal:  J Endocrinol Invest       Date:  2003-05       Impact factor: 4.256

6.  Differences in the Plasma Proteome of Patients with Hypothyroidism before and after Thyroid Hormone Replacement: A Proteomic Analysis.

Authors:  Assim A Alfadda; Hicham Benabdelkamel; Afshan Masood; Anwar A Jammah; Aishah A Ekhzaimy
Journal:  Int J Mol Sci       Date:  2018-01-01       Impact factor: 5.923

7.  Relationship between high normal TSH levels and metabolic syndrome components in type 2 diabetic subjects with euthyroidism.

Authors:  Lilit Petrosyan
Journal:  J Clin Transl Endocrinol       Date:  2015-02-26
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.